Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 3, Number 2—June 1997

Synopsis

Borna Disease

Carolyn G. Hatalski, Ann J. Lewis, and W. Ian LipkinComments to Author 
Author affiliations: University of California, Irvine, California, USA

Main Article

Table 1

Serum immunoreactivity to Borna disease virus in various diseases

Prevalence
Disease Disease (%) Controls (%) Assay Ref.
Psychiatric (4/694) 0.6 (0/200) 0 IFA (36)
(various) (13/642) 2 (11/540) 2 IFA (60)
(200-350/5000) 4-7 (10/1000) 1 WB IFA / (61)
(18/60) 30 (1/100) 1 WB (24, 25)
(18/132) 13.6 (3/203) 1.5 WB (27)
(13/55) 23.6 (4/36) 11.1 IFA (51)
(6/49) 12.2 IFA (38)
Affective (12/265) 4.5 (0/105) 0 IFA (62)
(12/285) 4.2 (0/200) 0 IFA (36)
(53/138) 38 (19/117) 16 WB (37)
(6/52) 11.5 (3/203) 1.4 WB (27)
(10/27) 37 IFA (38)
Schizophrenia (29/90) 32 (4/20) 20 WB (43)
(16/114) 14 (3/203) 1.5 WB (27)
(1/4) 25 IFA (38)
CFS (6/25) 24 WB (26)
MS (15/114) 13 (10/483) 2.1 IP/ IFA (63)
HIV-positive (36/460) 7.8 (11/540) 2 IFA (60)
HIV-early (61/751) 8.1 (10/483) 2 IP/ IFA (61)
HIV-LAP (34/244) 14 (10/483) 2 IP/ IFA (63)
Schisto/malaria (19/193) 9.8 (10/483) 2 IP/IFA (63)

Abbreviations: IFA, immunofluorescence assay; WB, Western immunoblot; IP, immunoprecipitation; CFS, chronic fatigue syndrome; MS, multiple sclerosis; HIV, human immunodeficiency virus; LAP, lymphadenopathy; Schisto/malaria, schistosomiasis or malaria.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO